COc1cc(OC)c(NC(=O)C(C)n2nc(-c3ccc(C)cc3)c3c(c2=O)CCCC3)cc1Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?